The Lancet, 27 June 2013 (In Press - DOI: 10.1016/S0140-6736(13)60733-3
Recently available on-line in The Lancet is a paper which describes the comparative efficacy and tolerability of 15 antipsychotics in people with schizophrenia written by a group in Germany with a track record of producing such studies. The difficulty with the evidence when comparing drug treatments is that where you have lots of pharmaceutical options there are rarely any head to head comparisons of the different treatments. One way to get a sense of comparative effectiveness is to do a meta-analysis of different studies.
The authors here combined the results of 212 blinded randomised controlled trials that included 43049 patients who had schizophrenia. They excluded studies where people had mainly negative symptoms, those who were treatment resistant and those done in stable patients (mainly relapse prevention studies). Of the people in the trials the mean duration of illness was about 12 years and they had an average age of 38 years.
Using a sophisticated form of metal
analysis they then produced hierarchies of effect sizes for overall efficacy,
discontinuation, weight gain, extrapyramidal side effects, prolactin increase,
QTc prolongation and sedation. What they found for overall efficacy is that
clozapine (by some margin) was the most effective followed by amisulpiride,
olanzapine and risperidone. Haloperidol
came in at seventh in the list. When looking at overall acceptability the top
three least likely to be discontinued compared to placebo were amisulpiride, olanzapine
and clozapine.
The true interest in this study is that it challenges
two ideas. The first is that all antipsychotics have the same effectiveness.
Whilst the difference in effectiveness between the drugs was small (and smaller
than for the side effects) it was a robust finding that didn’t alter much when
tested in the sensitivity analysis. The second challenge is that thinking about
antipsychotics as first generation or second generation isn’t very helpful as
it obscures differences in adverse effects between all antipsychotics. For
example aripiprazole is less sedating than quetiapine but haloperidol is
somewhere between; similarly olanzapine causes more weight gain than
risperidone but chlorpromazine is in between them.
As the authors state, “Antipsychotic drugs
differ in many properties and can therefore not be categorised in first
generation and second generation groupings. The suggested hierarchies in seven
major domains should help clinicians to adapt choice of antipsychotic drug to
the needs of individual patients”.
i relly need help with meds balance , where i live they wont give me a cbd oil . im the kind of guy whoo didnt left hes room for like four years and a half . my panic attacks were from people , and when i get a panic attack i go to a different reality so my question is ia there anything i can i help without meds can someone pleasr contact me with any imformation ? , i tried alt of stuff . and im always in a low frequency , and im a level that i dont like my self anymore , and english isnt my language , i hepe someone replay to me soon !!
ReplyDeletethis is my gmail if anyone can help , i can pay for that thousands , u just need to understand it .
ReplyDelete